CD8A and non-small cell lung carcinoma: With the development of new technologies for MAIT cell isolation and expansion and the construction of chimeric animal models, it provides us an opportunity to investigate the specific molecular mechanisms by which CD8+MAIT cells affects the efficacy of immunotherapy in patients with NSCLC.